thermal analysis software universal analysis 2000 for windows 2000, xp, vista version 4.5a (TA Instruments)
90
Structured Review
TA Instruments
thermal analysis software universal analysis 2000 for windows 2000, xp, vista version 4.5a
Thermal Analysis Software Universal Analysis 2000 For Windows 2000, Xp, Vista Version 4.5a, supplied by TA Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2000+thermal+analysis+software/thermal+analysis+software+universal+analysis+2000/pm39213452-72-0-13
Average 90 stars, based on 1 article reviews
Thermal Analysis Software Universal Analysis 2000 For Windows 2000, Xp, Vista Version 4.5a, supplied by TA Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2000+thermal+analysis+software/thermal+analysis+software+universal+analysis+2000/pm39213452-72-0-13
Average 90 stars, based on 1 article reviews
thermal analysis software universal analysis 2000 for windows 2000, xp, vista version 4.5a - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection. Article Snippet: The aim of this study was to identify an adequate formulation for a poorly soluble lead molecule (BI-A) that would achieve sufficiently high plasma concentrations after oral administration in dogs to enable a robust cardiovascular safety pharmacology assessment in telemetry-instrumented conscious dogs during lead optimization in drug discovery.. A spray-dried dispersion of BI-A (BI-A-SDD) containing a 1:2 ratio of BI-A and hydroxypropyl methylcellulose acetate succinate-LF was prepared using a Büchi spray dryer B-90 (B-90).. Physical form characterization, an in vitro dissolution test and a preliminary pharmacokinetic (PK) study following oral administration of BI-A-SDD were performed. |